Trials / Terminated
TerminatedNCT00209131
Efficacy of Flomax to Improve Stone Passage Following Shock Wave Lithotripsy
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Emory University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The majority of kidney stones are treated with shock wave lithotripsy (SWL). We are examining if the medication Flomax will result in improved stone passage rates following SWL.
Detailed description
Placebo blinded study examining the effects of Flomax on stone passage rates following SWL.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Flomax | 0.4mg Flomax pills will be given to patients to take once daily for one month following shock wave lithotripsy to aid the stone passage. |
| DRUG | Sugar pill | Comparable sugar pills will be given to the placebo group to take daily for one month following shock wave lithotripsy to aid stone passage. |
Timeline
- Start date
- 2005-04-01
- Primary completion
- 2009-02-01
- Completion
- 2009-02-01
- First posted
- 2005-09-21
- Last updated
- 2013-10-28
- Results posted
- 2012-07-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00209131. Inclusion in this directory is not an endorsement.